A detailed history of Alliancebernstein L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 405,705 shares of MRNA stock, worth $26.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
405,705
Previous 385,362 5.28%
Holding current value
$26.7 Million
Previous $41.1 Million 17.32%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $2.06 Million - $3.39 Million
20,343 Added 5.28%
405,705 $48.2 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $2.67 Million - $3.61 Million
-31,264 Reduced 7.5%
385,362 $41.1 Million
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $1.99 Million - $2.99 Million
-28,598 Reduced 6.42%
416,626 $41.4 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $4.62 Million - $6.07 Million
47,962 Added 12.07%
445,224 $46 Million
Q2 2023

Aug 15, 2023

SELL
$118.5 - $160.53 $187,230 - $253,637
-1,580 Reduced 0.4%
397,262 $48.3 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $12.5 Million - $18.1 Million
-91,916 Reduced 18.73%
398,842 $61.3 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $1.66 Million - $2.94 Million
-13,984 Reduced 2.77%
490,758 $88.1 Million
Q3 2022

Nov 15, 2022

SELL
$118.07 - $194.18 $667,921 - $1.1 Million
-5,657 Reduced 1.11%
504,742 $59.7 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $4.52 Million - $6.82 Million
38,595 Added 8.18%
510,399 $72.9 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $4.44 Million - $8.25 Million
-35,100 Reduced 6.92%
471,804 $81.3 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $5.85 Million - $9.54 Million
-25,884 Reduced 4.86%
506,904 $129 Million
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $77.7 Million - $170 Million
350,317 Added 191.99%
532,788 $205 Million
Q2 2021

Jul 30, 2021

BUY
$129.91 - $234.98 $2.05 Million - $3.7 Million
15,755 Added 9.45%
182,471 $42.9 Million
Q1 2021

May 06, 2021

BUY
$109.18 - $185.98 $705,630 - $1.2 Million
6,463 Added 4.03%
166,716 $21.8 Million
Q4 2020

Feb 08, 2021

SELL
$65.74 - $169.86 $2,563 - $6,624
-39 Reduced 0.02%
160,253 $16.7 Million
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $612,411 - $1.07 Million
11,270 Added 7.56%
160,292 $11.3 Million
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $910,898 - $2.46 Million
30,701 Added 25.95%
149,022 $9.57 Million
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $370,890 - $658,758
20,860 Added 21.4%
118,321 $3.54 Million
Q4 2019

Feb 18, 2020

BUY
$13.93 - $21.28 $515,967 - $788,211
37,040 Added 61.3%
97,461 $1.91 Million
Q3 2019

Nov 14, 2019

BUY
$12.26 - $18.07 $81,700 - $120,418
6,664 Added 12.4%
60,421 $962,000
Q2 2019

Aug 14, 2019

BUY
$13.7 - $28.34 $479,911 - $992,750
35,030 Added 187.06%
53,757 $787,000
Q1 2019

May 14, 2019

BUY
$14.45 - $23.7 $270,605 - $443,829
18,727 New
18,727 $381,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.